Kaya Holdings (KAYS) Net Cash Flow (2011 - 2025)
Kaya Holdings (KAYS) recorded quarterly Net Cash Flow of -$42710.0 in Q3 2025, down 409.54% quarter-over-quarter from -$8382.0 in Q2 2025, and down 119.17% on a YoY basis from $222772.0 in Q3 2024.
Kaya Holdings (KAYS) Net Cash Flow (2011 - 2025) Analysis & Trends
Kaya Holdings' Net Cash Flow history runs 15 years deep, the most recent figure standing at -$42710.0 for Q3 2025.
- In Q3 2025, Net Cash Flow fell 119.17% year-over-year to -$42710.0; the TTM figure through Sep 2025 stood at -$117405.0 (down 232.88% YoY), while the FY2024 annual figure was $177299.0, up 242.4% from the prior year.
- Net Cash Flow was -$42710.0 for Q3 2025 at Kaya Holdings, down from -$8382.0 in the prior quarter.
- In the past five years, Net Cash Flow ranged from a high of $510466.0 in Q4 2021 to a low of -$509474.0 in Q2 2022.
- Historically, Net Cash Flow has averaged -$26716.0 across 5 years, with a median of -$15948.0 in 2022.
- The sharpest annual moves came in 2021 and 2022: Net Cash Flow jumped 3367.13% in 2021, then sank 1937.27% in 2022.
- A 5-year view of Net Cash Flow shows it stood at $510466.0 in 2021, then tumbled by 103.12% to -$15948.0 in 2022, then tumbled by 945.15% to -$166681.0 in 2023, then surged by 53.36% to -$77739.0 in 2024, then soared by 45.06% to -$42710.0 in 2025.
- The last three Net Cash Flow figures came in at -$42710.0 (Q3 2025), -$8382.0 (Q2 2025), and $11426.0 (Q1 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Cash Flow (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 39.97 Bn | 36.23 Bn | 1.97 Bn | 202.00 Mn |
| 2 | Zoetis | 33.59 Bn | 31.65 Bn | 1.62 Bn | -526.00 Mn |
| 3 | United Therapeutics | 23.75 Bn | 21.60 Bn | 648.10 Mn | -277.40 Mn |
| 4 | Neurocrine Biosciences | 16.10 Bn | 14.78 Bn | 800.70 Mn | -446.50 Mn |
| 5 | Aurora Cannabis | 15.56 Bn | 15.47 Bn | 21.72 Mn | - |
| 6 | Elanco Animal Health | 12.04 Bn | 11.61 Bn | 785.00 Mn | -112.00 Mn |
| 7 | Alkermes | 7.36 Bn | 6.84 Bn | -116.06 Mn | -768.22 Mn |
| 8 | Lantheus Holdings | 6.74 Bn | 6.24 Bn | 230.92 Mn | 139.49 Mn |
| 9 | Liquidia | 6.27 Bn | 6.04 Bn | 121.79 Mn | 32.11 Mn |
| 10 | Kaya Holdings | - | - | 5,370.00 | -42,710.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | -42,710.00 |
| Sep 30, 2025 | -42,710.00 |
| Jun 30, 2025 | -8,382.00 |
| Jun 30, 2025 | -8,382.00 |
| Mar 31, 2025 | 11,426.00 |
| Mar 31, 2025 | 11,426.00 |
| Dec 31, 2024 | -77,739.00 |
| Dec 31, 2024 | -77,739.00 |
| Sep 30, 2024 | 222,772.00 |
| Sep 30, 2024 | 222,772.00 |
| Jun 30, 2024 | -73,428.00 |
| Jun 30, 2024 | -73,428.00 |
| Mar 31, 2024 | 105,694.00 |
| Mar 31, 2024 | 105,694.00 |
| Dec 31, 2023 | -166,681.00 |
| Dec 31, 2023 | -166,681.00 |
| Sep 30, 2023 | -64,934.00 |
| Sep 30, 2023 | -64,934.00 |
| Jun 30, 2023 | 94,619.00 |
| Jun 30, 2023 | 94,619.00 |